Related Experiment Video
Updated: May 2, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
DNAJB4/HLJ1 protects against acetaminophen-induced liver injury by attenuating ER stress via HSP70
Chih-Yun Lu1, Tsung-Hsuan Hsieh1, Min-Hui Chien1
1Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract:
Drug-induced liver injury (DILI) remains a leading cause of acute liver failure; however, current clinical strategies lack reliable biomarkers, predictors of susceptibility, and effective therapeutic interventions. Among these etiologies, acetaminophen (APAP) overdose is the most common cause of DILI worldwide. Heat shock proteins (HSPs), particularly members of the HSP40 family, are central regulators of cellular stress responses, yet the specific role of DNAJB4/HLJ1 in APAP-induced hepatotoxicity remains poorly defined. To address this gap, we employed DNAJB4/HLJ1-deficient mice (Dnajb4-/-) to investigate the function of DNAJB4/HLJ1 in APAP-induced liver injury. Following APAP administration (> 400 mg/kg), Dnajb4-/- exhibited exacerbated hepatic necrosis, elevated liver enzymes, and enhanced c-jun/JNK activation compared with Dnajb4+/+ controls. Metabolic profiling revealed altered APAP metabolism, with reduced detoxification products and excessive oxidative metabolites, and pronounced glutathione (GSH) depletion. Transcriptomic analysis implicated DNAJB4/HLJ1 in metabolism, protein folding, and endoplasmic reticulum (ER) stress via interaction with HSP70. Consistently, ATF6, XBP1, and CHOP expression confirmed aggravated ER stress in Dnajb4-/- livers. AlphaFold-Multimer modeling and co-immunoprecipitation validated physical interaction between DNAJB4/HLJ1 and HSP70. Restoration of DNAJB4/HLJ1 expression attenuated ER stress, c-jun/JNK activation, and liver injury, while pharmacological inhibition of ER stress confirmed its mechanistic involvement. Collectively, these findings identify DNAJB4/HLJ1 as a previously unrecognized regulator of stress signaling in APAP-induced hepatotoxicity. By modulating ER stress within the integrated cellular stress network, DNAJB4/HLJ1 limits injury progression and promotes hepatocellular resilience, highlighting its potential as a novel therapeutic target for preventing or mitigating DILI.
Insights
DNAJB4/HLJ1 deficiency worsens acetaminophen-induced liver injury by increasing endoplasmic reticulum stress. Restoring DNAJB4/HLJ1 expression protects against liver damage, suggesting it as a therapeutic target for drug-induced liver injury.
Area of Science:
- Hepatology
- Molecular Biology
- Cellular Stress Response
Background:
- Drug-induced liver injury (DILI) is a major cause of acute liver failure, lacking reliable biomarkers and treatments.
- Acetaminophen (APAP) overdose is the most frequent cause of DILI globally.
- The role of Heat Shock Protein 40 family member DNAJB4/HLJ1 in APAP hepatotoxicity is unclear.
Purpose of the Study:
- Investigate the function of DNAJB4/HLJ1 in APAP-induced liver injury using gene-deficient mice.
- Elucidate the molecular mechanisms underlying DNAJB4/HLJ1's role in hepatotoxicity.
- Assess DNAJB4/HLJ1 as a potential therapeutic target for DILI.
Main Methods:
- Utilized DNAJB4/HLJ1-deficient mice (Dnajb4-/-) and wild-type controls (Dnajb4+/+).
- Administered acetaminophen (APAP) and assessed liver injury markers, metabolic profiles, and gene expression.
- Employed transcriptomic analysis, AlphaFold-Multimer modeling, and co-immunoprecipitation to study protein interactions and cellular pathways.
- Investigated the role of endoplasmic reticulum (ER) stress and c-jun/JNK activation.
Main Results:
- Dnajb4-/- mice showed exacerbated liver necrosis, elevated liver enzymes, and increased c-jun/JNK activation post-APAP.
- Metabolic profiling revealed altered APAP metabolism, reduced detoxification, increased oxidative metabolites, and glutathione depletion in deficient mice.
- Transcriptomic and molecular analyses confirmed aggravated ER stress and identified a physical interaction between DNAJB4/HLJ1 and HSP70.
- Restoration of DNAJB4/HLJ1 attenuated ER stress, c-jun/JNK activation, and liver injury.
Conclusions:
- DNAJB4/HLJ1 acts as a critical regulator of cellular stress signaling in APAP-induced hepatotoxicity.
- DNAJB4/HLJ1 mitigates liver injury by modulating ER stress and promoting hepatocellular resilience.
- DNAJB4/HLJ1 represents a promising therapeutic target for preventing or treating DILI.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of the Unfolded Protein Response
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

